首页> 外文期刊>Endocrine Pathology >Angiogenesis and the growth potential of craniopharyngiomas
【24h】

Angiogenesis and the growth potential of craniopharyngiomas

机译:血管生成和颅咽神经瘤的生长潜力

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was performed to evaluate the role of neovascularization on the behavior of craniopharyngiomas as well as the contribution of endothelial cell proliferation and migration in the remodeling and expansion of the vascular network associated with angiogenesis. Fourteen primary tumors were studied, all of the adamantinomatous type. CD34 immunostaining, an endothelial cell marker, localized vessels within the connective tissue stroma. MIB-1 immunopositivity was apparent in the nuclei of neoplastic cells, few endothelial cells, and stromal elements. MIB-1 counts were higher in epithelial than connective tissue cells. A positive correlation was found between the number of MIB-1 immunopositive cells and microvessel density (MVD). Immunohistochemistry demonstrated that integrin αvβ3 expression was restricted to tumor vasculature; the tumor cells were immunonegative. Only 2.5% of vessels detected with CD34 were immunopositive for integrin αvβ3. At present, no therapeutic implications can be drawn from our observations. More studies are needed to assess whether integrin αvβ3 antagonists or drugs that arrest the cell cycle of endothelial cells can inhibit angiogenesis in craniopharyngiomas.
机译:本研究旨在评估新血管形成对颅咽管瘤行为的作用以及内皮细胞增殖和迁移在与血管生成相关的血管网络重塑和扩展中的作用。研究了14种原发性肿瘤,均为金刚毛瘤类型。 CD34免疫染色是一种内皮细胞标志物,位于结缔组织基质内的血管中。 MIB-1免疫阳性在肿瘤细胞的核,少量内皮细胞和基质成分中很明显。上皮中的MIB-1计数高于结缔组织细胞。发现MIB-1免疫阳性细胞数量与微血管密度(MVD)之间呈正相关。免疫组织化学证实整联蛋白αvβ3的表达受肿瘤血管的限制。肿瘤细胞是免疫阴性的。用CD34检测到的血管中只有2.5%对整联蛋白αvβ3免疫阳性。目前,我们的观察结果尚无治疗意义。需要更多的研究来评估整联蛋白αvβ3拮抗剂或阻滞内皮细胞细胞周期的药物是否可以抑制颅咽管瘤的血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号